With the end goal of reimaging global drug development, Novartis several years ago positioned themselves to “Go Big on Data” […]
An Elsevier Feature piece published this week evaluates the risks and rewards of artificial intelligence in driving “digital R&D” within […]
In a 2019 survey of senior executives, directors, and CEOs, digital transformation was collectively cited as their biggest risk concern. Why then […]
